Oscillating CD8(+) T cell effector functions after antigen recognition in the liver.
暂无分享,去创建一个
[1] A. Oxenius,et al. Immediate Cytotoxicity But Not Degranulation Distinguishes Effector and Memory Subsets of CD8+ T Cells , 2004, The Journal of experimental medicine.
[2] Aaruni Khanolkar,et al. Maintenance, Loss, and Resurgence of T Cell Responses During Acute, Protracted, and Chronic Viral Infections1 , 2004, The Journal of Immunology.
[3] Graeme E Price,et al. Differential Tissue-Specific Regulation of Antiviral CD8+ T-Cell Immune Responses during Chronic Viral Infection , 2004, Journal of Virology.
[4] R. Purcell,et al. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[5] L. Lefrançois,et al. IL-2 Is Not Required for the Initiation of CD8 T Cell Cycling but Sustains Expansion 1 , 2003, The Journal of Immunology.
[6] Yoshimasa Tanaka,et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice , 2003, Nature Medicine.
[7] Reinhold Schirmbeck,et al. Different immunogenicity of H‐2 Kb‐restricted epitopes in natural variants of the hepatitis B surface antigen , 2003, European journal of immunology.
[8] E. Wherry,et al. Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment , 2003, Journal of Virology.
[9] Rustom Antia,et al. Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.
[10] R. Purcell,et al. CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.
[11] A. Satoskar,et al. A Unique Mechanism for Innate Cytokine Promotion of T Cell Responses to Viral Infections1 , 2002, The Journal of Immunology.
[12] J. Sprent,et al. Interleukin 15 Controls both Proliferation and Survival of a Subset of Memory-Phenotype CD8+ T Cells , 2002, The Journal of experimental medicine.
[13] Yoshimasa Tanaka,et al. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Sette,et al. Immunogenicity and Tolerogenicity of Hepatitis B Virus Structural and Nonstructural Proteins: Implications for Immunotherapy of Persistent Viral Infections , 2002, Journal of Virology.
[15] Haidong Dong,et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.
[16] W. Leonard,et al. The basis for TCR‐mediated regulation of the IL‐2 receptor α chain gene: role of widely separated regulatory elements , 2002, The EMBO journal.
[17] L. Lefrançois,et al. Essential Role for IL-2 in the Regulation of Antiviral Extralymphoid CD8 T Cell Responses1 , 2002, The Journal of Immunology.
[18] R. Bleackley,et al. Cytotoxic T lymphocytes: all roads lead to death , 2002, Nature Reviews Immunology.
[19] F. Chisari,et al. Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection , 2001, The Journal of experimental medicine.
[20] G. Freeman,et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation , 2001, Nature Immunology.
[21] L. Lefrançois,et al. Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue , 2001, Science.
[22] J. Sidney,et al. Overcoming T Cell Tolerance to the Hepatitis B Virus Surface Antigen in Hepatitis B Virus-Transgenic Mice1 , 2001, The Journal of Immunology.
[23] G. Freeman,et al. Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.
[24] F. Chisari,et al. Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo , 2000, The Journal of experimental medicine.
[25] J. Whitton,et al. Antigen-specific regulation of T cell-mediated cytokine production. , 2000, Immunity.
[26] B. Walker,et al. Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.
[27] F. Chisari,et al. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. , 2000, The American journal of pathology.
[28] F. Chisari,et al. Relative Sensitivity of Hepatitis B Virus and Other Hepatotropic Viruses to the Antiviral Effects of Cytokines , 2000, Journal of Virology.
[29] J. Harty,et al. CD8+ T cell effector mechanisms in resistance to infection. , 2000, Annual review of immunology.
[30] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[31] Fernando Rodriguez,et al. Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells , 1999, Nature.
[32] M. Shapiro,et al. Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.
[33] F. Chisari,et al. Polyclonality and multispecificity of the CTL response to a single viral epitope. , 1998, Journal of immunology.
[34] J. Altman,et al. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. , 1998, Immunity.
[35] J. Sprent,et al. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. , 1998, Immunity.
[36] J. Altman,et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.
[37] E. Lara-Pezzi,et al. Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1. , 1997, Journal of immunology.
[38] A. McMichael,et al. Rapid Effector Function in CD8+ Memory T Cells , 1997, The Journal of experimental medicine.
[39] F. Chisari,et al. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes. , 1997, International immunology.
[40] F. Chisari,et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.
[41] F. Chisari,et al. High-level hepatitis B virus replication in transgenic mice , 1995, Journal of virology.
[42] G Berke,et al. The CTL's kiss of death , 1995, Cell.
[43] F. Chisari,et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis , 1993, The Journal of experimental medicine.
[44] R. Palmiter,et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. , 1990, Science.
[45] R. Testi,et al. T cell activation via Leu-23 (CD69). , 1989, Journal of immunology.
[46] T. Waldmann,et al. Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[47] T. Waldmann,et al. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor , 1982, Nature.